RecruitingPhase 1Phase 2NCT06545890

Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries

Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries: A Randomized Controlled Study.


Sponsor

Cairo University

Enrollment

46 participants

Start Date

Aug 10, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of the study is to compare the effectiveness of ketofol for the prevention of emergence delirium in pediatric patients undergoing squint surgery, in comparison to dexmedetomidine.


Eligibility

Min Age: 2 YearsMax Age: 6 Years

Inclusion Criteria4

  • All pediatric patients aged 2 to 6 years.
  • Both sexes.
  • ASA physical status I and II.
  • Patients undergoing squint surgery.

Exclusion Criteria3

  • Refusal of parents.
  • Patient sensitivity to any of the study medications.
  • Known neurological disease that can affect the assessment of ED postoperatively.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGKetamine

continous infusion during surgery

DRUGDexmedetomidine

continous infusion during surgery


Locations(2)

Abu Elresh Hospitals ( Cairo university )

Cairo, Egypt

Abu ElResh hospital

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06545890


Related Trials